| Tachyarrhythmias |
| Clinical
features Investigations Therapy Prevention Prognosis |
Supraventricular tachycardia Why?
SVT: nadolol helps slow the ventricular rate and cardioversion
|
Expiry date:
July 2004
Levels of Evidence used in grading these guides
| Author | CM Ball |
| Reviewer | H Oral |
| CAT Writers | CM Ball , N Shenker , CJ Wotton |